Dagnogo Oléfongo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dagnogo Oléfongo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Bla Kouakou Brice
3 shared publicationsDjaman Allico Joseph
3 shared publications- Allico Joseph Djaman
Health and Biology, Félix Houphouët-Boigny University, Abidjan, Cote d’Ivoire;Fundamental and Medical Biochemistry, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire
2 shared publications - Dougba Noel Dago
Department of Genetics and Biochemistry, Peleforo GON COULIBALY University, Korhogo, Côte d’Ivoire
2 shared publications Kouman Kouamé Bouatini Angélo
2 shared publications- Kouman Kouamé Bouatini Angélo
Department of Parasitology-Mycology, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire
2 shared publications
Latest Publications
- 24 July 2025
- Published by Sciencedomain International in Journal of Advances in Biology & Biotechnology
- Vol. 28 (8) , 1406-1416
Transcription Factor 7-Like 2 (TCF7L2) rs12255372 Gene Polymorphism in Non-diabetic Hypertensive Patients in Abidjan, Côte d’Ivoire
Background: The association of the Transcription Factor 7-Like 2 (TCF7L2) gene with type 2 diabetes mellitus (T2DM) has been demonstrated in several populations of diverse genetic origins. Studies have also shown that 13% of non-diabetic hypertensives develop diabetes. Objective: The aim of this study was to identify the TCF7L2 gene polymorphism (rs12255372 G > T) in non-diabetic hypertensive patients in order to contribute to better management of their disease. Methodology: This was a prospective cross-sectional study realized with one hundred and sixty (160) non-diabetic patients, 100 of whom suffered from arterial hypertension. Participants were recruited at the Government Employees' Medical Service (GEMS) in Abidjan, Côte d’Ivoire. After obtaining consent, a blood sample was taken from each participant for glycaemia measurement and confetti realization for molecular biology. Genomic DNA extracted from the confetti was used to perform TCF7L2 gene genotyping using allele-specific PCR. Results: The results of this study concluded that the polymorphism of the rs12255372 allele of the TCF7L2 gene associated with predisposition to type 2 diabetes was not detected in non-diabetic hypertensive patients in Abidjan, Côte d’Ivoire.
- 24 July 2025
- Published by Sciencedomain International in Journal of Advances in Biology & Biotechnology
- Vol. 28 (8) , 1406-1416
Transcription Factor 7-Like 2 (TCF7L2) rs12255372 Gene Polymorphism in Non-diabetic Hypertensive Patients in Abidjan, Côte d’Ivoire
Background: The association of the Transcription Factor 7-Like 2 (TCF7L2) gene with type 2 diabetes mellitus (T2DM) has been demonstrated in several populations of diverse genetic origins. Studies have also shown that 13% of non-diabetic hypertensives develop diabetes. Objective: The aim of this study was to identify the TCF7L2 gene polymorphism (rs12255372 G > T) in non-diabetic hypertensive patients in order to contribute to better management of their disease. Methodology: This was a prospective cross-sectional study realized with one hundred and sixty (160) non-diabetic patients, 100 of whom suffered from arterial hypertension. Participants were recruited at the Government Employees' Medical Service (GEMS) in Abidjan, Côte d’Ivoire. After obtaining consent, a blood sample was taken from each participant for glycaemia measurement and confetti realization for molecular biology. Genomic DNA extracted from the confetti was used to perform TCF7L2 gene genotyping using allele-specific PCR. Results: The results of this study concluded that the polymorphism of the rs12255372 allele of the TCF7L2 gene associated with predisposition to type 2 diabetes was not detected in non-diabetic hypertensive patients in Abidjan, Côte d’Ivoire.
- Open Access
- 11 July 2025
- Published by Science Alert in Research Journal of Parasitology
- Vol. 20 (1) , 1-8
Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts
Background and Objective: Malaria is one of the main causes of morbidity and mortality in the world, particularly in endemic areas. Its management is hampered by the resistance of Plasmodium falciparumto almost all anti-malarial drugs. Mutations in the pfcrt (Plasmodium falciparum Chloroquine Resistance Transporter) gene are associated with Plasmodium falciparum resistance to chloroquine (CQ), and more specifically, mutations at loci 72 to 76 located in the second exon of the gene. This study aims to explore the return of Plasmodium falciparum’s sensitivity to chloroquine in two health districts of Southern Côte d'Ivoire through pfcrt gene polymorphisms. Materials and Methods: After obtaining informed consent, blood samples were collected from patients of all sexes and ages with uncomplicated P. falciparummalaria at Dabou General Hospital and Anonkoua-Kouté Health Centre, located in the South of Côte d'Ivoire, in the Dabou and Abidjan 1 health districts, respectively. Plamodium falciparumgenomic DNA was extracted and amplified by nested-PCR using primers specific for the pfcrtgene. Amplification products were sequenced using the Sanger method at Eurofins Genomics. Key codons (72, 73, 74, 75, and 76), molecular markers of P. falciparumresistance to chloroquine, were analyzed. Data were analyzed in R using the χ 2 test to compare pfcrt allele and genotype prevalences, with significance set at p0.05). Conclusion: Nearly twenty years after chloroquine was abandoned as a treatment for uncomplicated malaria in Côte d'Ivoire, the proportion of parasites sensitive to this antimalarial appears to be increasing in the south of the country, particularly in the health districts of Dabou and Abidjan 1. APA-7 Style Oléfongo, D., Bérenger, A.A., Anne-Edwige, C.G., Angélo, K.K., Brice, B.K., André, T.O., Joseph, D.A. (2025). Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts. Research Journal of Parasitology, 20(1), 1-8. https://doi.org/10.3923/parasite.2025.01.08 ACS Style Oléfongo, D.; Bérenger, A.A.; Anne-Edwige, C.G.; Angélo, K.K.; Brice, B.K.; André, T.O.; Joseph, D.A. Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts. Res. J. Parasitol 2025, 20, 1-8. https://doi.org/10.3923/parasite.2025.01.08 AMA Style Oléfongo D, Bérenger AA, Anne-Edwige CG, Angélo KK, Brice BK, André TO, Joseph DA. Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts. Research Journal of Parasitology. 2025; 20(1): 1-8. https://doi.org/10.3923/parasite.2025.01.08 Chicago/Turabian Style Oléfongo, Dagnogo, Ako Ako Aristide Bérenger, Coulibaly Gninwélé Anne-Edwige, Kouman Kouamé Bouatini Angélo, Bla Kouakou Brice, Touré Offianan André, and Djaman Allico Joseph. 2025. "Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts" Research Journal of Parasitology 20, no. 1: 1-8. https://doi.org/10.3923/parasite.2025.01.08
- 11 July 2025
- Published by Science Alert in Research Journal of Parasitology
- Vol. 20 (1) , 1-8
Open AccessRe-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts
Background and Objective: Malaria is one of the main causes of morbidity and mortality in the world, particularly in endemic areas. Its management is hampered by the resistance of Plasmodium falciparumto almost all anti-malarial drugs. Mutations in the pfcrt (Plasmodium falciparum Chloroquine Resistance Transporter) gene are associated with Plasmodium falciparum resistance to chloroquine (CQ), and more specifically, mutations at loci 72 to 76 located in the second exon of the gene. This study aims to explore the return of Plasmodium falciparum’s sensitivity to chloroquine in two health districts of Southern Côte d'Ivoire through pfcrt gene polymorphisms. Materials and Methods: After obtaining informed consent, blood samples were collected from patients of all sexes and ages with uncomplicated P. falciparummalaria at Dabou General Hospital and Anonkoua-Kouté Health Centre, located in the South of Côte d'Ivoire, in the Dabou and Abidjan 1 health districts, respectively. Plamodium falciparumgenomic DNA was extracted and amplified by nested-PCR using primers specific for the pfcrtgene. Amplification products were sequenced using the Sanger method at Eurofins Genomics. Key codons (72, 73, 74, 75, and 76), molecular markers of P. falciparumresistance to chloroquine, were analyzed. Data were analyzed in R using the χ 2 test to compare pfcrt allele and genotype prevalences, with significance set at p0.05). Conclusion: Nearly twenty years after chloroquine was abandoned as a treatment for uncomplicated malaria in Côte d'Ivoire, the proportion of parasites sensitive to this antimalarial appears to be increasing in the south of the country, particularly in the health districts of Dabou and Abidjan 1. APA-7 Style Oléfongo, D., Bérenger, A.A., Anne-Edwige, C.G., Angélo, K.K., Brice, B.K., André, T.O., Joseph, D.A. (2025). Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts. Research Journal of Parasitology, 20(1), 1-8. https://doi.org/10.3923/parasite.2025.01.08 ACS Style Oléfongo, D.; Bérenger, A.A.; Anne-Edwige, C.G.; Angélo, K.K.; Brice, B.K.; André, T.O.; Joseph, D.A. Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts. Res. J. Parasitol 2025, 20, 1-8. https://doi.org/10.3923/parasite.2025.01.08 AMA Style Oléfongo D, Bérenger AA, Anne-Edwige CG, Angélo KK, Brice BK, André TO, Joseph DA. Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts. Research Journal of Parasitology. 2025; 20(1): 1-8. https://doi.org/10.3923/parasite.2025.01.08 Chicago/Turabian Style Oléfongo, Dagnogo, Ako Ako Aristide Bérenger, Coulibaly Gninwélé Anne-Edwige, Kouman Kouamé Bouatini Angélo, Bla Kouakou Brice, Touré Offianan André, and Djaman Allico Joseph. 2025. "Re-Emerging Chloroquine Sensitivity of Plasmodium falciparum in Côte d'Ivoire: Analysis of pfcrt Gene Polymorphism in Two Health Districts" Research Journal of Parasitology 20, no. 1: 1-8. https://doi.org/10.3923/parasite.2025.01.08
- Open Access
- 22 January 2025
- Published by Science Publishing Group in International Journal of Genetics and Genomics
- Vol. 13 (1) , 10-19
Polymorphism of the rs12255372 Allele of the TCF7L2 Gene Associated with Predisposition to Type 2 Diabete Using SNP Markers in a Population in the North of the Côte d’Ivoire
Background : Type 2 diabetes (T2D) is a chronic metabolic disease characterised by hyperglycaemia due to insulin resistance and impaired insulin secretion. Genetic and environmental factors can influence predisposition to this disease. Genetic predisposition plays a significant role in the risk of developing the disease, and the TCF7L2 (T-Cell Factor-Like 2) gene is one of the main genes associated with type 2 diabetes. Objective: The aim of this study was to investigate the prevalence of the rs12255372 (G/T) polymorphism in TCF7L2, a gene associated with the risk of type 2 diabete (T2D) in the Ivorian population in the north of Côte d'Ivoire. Methodology : We included a total of 75 participants, 50 with type 2 diabete and 25 healthy subjects, for various anthropometric, clinical and genetic parameters. Participants were recruited from the Korhogo Regional Hospital. After obtaining consent, a blood sample was taken from each participant for glycaemia measurement and confetti realization for molecular biology. Genomic DNA extracted from the confetti was used to perform TCF7L2 gene genotyping using allele-specific PCR. Results : Analysis of the prevalence of the T allele of the SNP rs12255372 showed a statistically significant association between type 2 diabetic patients and non-diabetics (p≤0.05). The analysis revealed a genotypic prevalence of the rs12255372 variant of the TT allele significantly more expressed in non-diabetics (52%) compared with diabetics (26%) (p=0.03, z=2.23). Conclusion : This study revealed a high prevalence of the rs12255372 genetic variant of the TCF7L2 gene in non-diabetic populations in the north of Côte d'Ivoire, suggesting a significant predisposition to types 2 diabetes and the involvement of other factors, such as environmental conditions, lifestyle habits and genetic interactions in the development of type 2 diabetes in healthy subjects carrying the TT allele of the SNP rs12255372 of the TCF7L2 gene.
- 22 January 2025
- Published by Science Publishing Group in International Journal of Genetics and Genomics
- Vol. 13 (1) , 10-19
Open AccessPolymorphism of the rs12255372 Allele of the TCF7L2 Gene Associated with Predisposition to Type 2 Diabete Using SNP Markers in a Population in the North of the Côte d’Ivoire
Background : Type 2 diabetes (T2D) is a chronic metabolic disease characterised by hyperglycaemia due to insulin resistance and impaired insulin secretion. Genetic and environmental factors can influence predisposition to this disease. Genetic predisposition plays a significant role in the risk of developing the disease, and the TCF7L2 (T-Cell Factor-Like 2) gene is one of the main genes associated with type 2 diabetes. Objective: The aim of this study was to investigate the prevalence of the rs12255372 (G/T) polymorphism in TCF7L2, a gene associated with the risk of type 2 diabete (T2D) in the Ivorian population in the north of Côte d'Ivoire. Methodology : We included a total of 75 participants, 50 with type 2 diabete and 25 healthy subjects, for various anthropometric, clinical and genetic parameters. Participants were recruited from the Korhogo Regional Hospital. After obtaining consent, a blood sample was taken from each participant for glycaemia measurement and confetti realization for molecular biology. Genomic DNA extracted from the confetti was used to perform TCF7L2 gene genotyping using allele-specific PCR. Results : Analysis of the prevalence of the T allele of the SNP rs12255372 showed a statistically significant association between type 2 diabetic patients and non-diabetics (p≤0.05). The analysis revealed a genotypic prevalence of the rs12255372 variant of the TT allele significantly more expressed in non-diabetics (52%) compared with diabetics (26%) (p=0.03, z=2.23). Conclusion : This study revealed a high prevalence of the rs12255372 genetic variant of the TCF7L2 gene in non-diabetic populations in the north of Côte d'Ivoire, suggesting a significant predisposition to types 2 diabetes and the involvement of other factors, such as environmental conditions, lifestyle habits and genetic interactions in the development of type 2 diabetes in healthy subjects carrying the TT allele of the SNP rs12255372 of the TCF7L2 gene.
- Open Access
- 8 July 2024
- Published by Science Publishing Group in International Journal of Microbiology and Biotechnology
- Vol. 9 (3) , 68-78
Assessment of Saliva and Urine Performance for Antimalarial Drug Resistance Molecular Markers Study
Background : The malaria diagnostic tools developed to date require blood to be taken. However, certain groups in the population are reluctant to take blood samples because of their cultural habits (blood taboo), or because of the fear associated with the trauma of the injection, especially when the sample is taken repeatedly. Saliva and urine, which are not very invasive to collect, have not been widely used for malaria diagnosis. The aim of this study is to assess the performance of saliva and urine in detecting molecular markers of Plasmodium falciparum resistance to antimalarial drugs. Methodology : Blood, urine and saliva samples were collected in three different localities from 94 patients over 2 years of age with microscopically confirmed Plasmodium falciparum uncomplicated malaria. P. falciparum genomic DNA (Deoxyribonucleic acid) was then extracted and amplified using primers specific for the Pfcrt (Plasmodium falciparum Chloroquine Resistance Transporter), Pfdhfr (Plasmodium falciparum dihydrofolate reductase) and PfK13 propeller (Plasmodium falciparum Kelch13 propeller) genes. The amplification products were processed by electrophoresis and analyzed against blood, saliva and urine samples. A multivariate statistical analysis in R programming environment was performed aiming to assess the performance of blood, saliva and urine samples in detecting molecular markers of P. falciparum resistance. Results : Agarose gel electrophoresis of the amplification products of each gene detected the Pfcrt genes at 80.85% (76/94), Pfdhfr at 95.74% (90/94) and PfK13 Propeller at 98.93% (93/94) in blood. In saliva, gene detection levels were 50% (47/94), 69.14% (65/94) and 4.26% (4/94) respectively for the K13 propeller, Pfdhfr and Pfcrt genes. Unlike the Pfcrt gene, which was not detected, 45.74% (43/94) and 38.30% (36/94) of PfK13 Propeller and pfdhfr genes respectively were detected in urine. Taking blood as the reference biological sample, statistical analysis showed that unlike urine, saliva exhibited a detection performance for molecular markers of antimalarial drug resistance ( pfcrt, pfdhfr , pfK13 propeller) close to that of blood (p < 0.05). The performance of saliva and urine was also assessed on the basis of the detection of the molecular markers pfdhfr , pfcrt and pfK13 using ROC ( receiver operational characteristic ) analysis. The data revealed a high sensitivity of saliva compared with urine in the detection of the pfdhfr , pfcrt and pfK13 propeller genes. Conclusion : The levels of detection of molecular markers of antimalarial drug resistance studied in saliva are close to those in blood. Saliva is a high-performance biological product that could potentially be used as an alternative non-invasive sample for the study of molecular markers of Plasmodium falciparum resistance to antimalarial drugs.
- 8 July 2024
- Published by Science Publishing Group in International Journal of Microbiology and Biotechnology
- Vol. 9 (3) , 68-78
Open AccessAssessment of Saliva and Urine Performance for Antimalarial Drug Resistance Molecular Markers Study
Background : The malaria diagnostic tools developed to date require blood to be taken. However, certain groups in the population are reluctant to take blood samples because of their cultural habits (blood taboo), or because of the fear associated with the trauma of the injection, especially when the sample is taken repeatedly. Saliva and urine, which are not very invasive to collect, have not been widely used for malaria diagnosis. The aim of this study is to assess the performance of saliva and urine in detecting molecular markers of Plasmodium falciparum resistance to antimalarial drugs. Methodology : Blood, urine and saliva samples were collected in three different localities from 94 patients over 2 years of age with microscopically confirmed Plasmodium falciparum uncomplicated malaria. P. falciparum genomic DNA (Deoxyribonucleic acid) was then extracted and amplified using primers specific for the Pfcrt (Plasmodium falciparum Chloroquine Resistance Transporter), Pfdhfr (Plasmodium falciparum dihydrofolate reductase) and PfK13 propeller (Plasmodium falciparum Kelch13 propeller) genes. The amplification products were processed by electrophoresis and analyzed against blood, saliva and urine samples. A multivariate statistical analysis in R programming environment was performed aiming to assess the performance of blood, saliva and urine samples in detecting molecular markers of P. falciparum resistance. Results : Agarose gel electrophoresis of the amplification products of each gene detected the Pfcrt genes at 80.85% (76/94), Pfdhfr at 95.74% (90/94) and PfK13 Propeller at 98.93% (93/94) in blood. In saliva, gene detection levels were 50% (47/94), 69.14% (65/94) and 4.26% (4/94) respectively for the K13 propeller, Pfdhfr and Pfcrt genes. Unlike the Pfcrt gene, which was not detected, 45.74% (43/94) and 38.30% (36/94) of PfK13 Propeller and pfdhfr genes respectively were detected in urine. Taking blood as the reference biological sample, statistical analysis showed that unlike urine, saliva exhibited a detection performance for molecular markers of antimalarial drug resistance ( pfcrt, pfdhfr , pfK13 propeller) close to that of blood (p < 0.05). The performance of saliva and urine was also assessed on the basis of the detection of the molecular markers pfdhfr , pfcrt and pfK13 using ROC ( receiver operational characteristic ) analysis. The data revealed a high sensitivity of saliva compared with urine in the detection of the pfdhfr , pfcrt and pfK13 propeller genes. Conclusion : The levels of detection of molecular markers of antimalarial drug resistance studied in saliva are close to those in blood. Saliva is a high-performance biological product that could potentially be used as an alternative non-invasive sample for the study of molecular markers of Plasmodium falciparum resistance to antimalarial drugs.
- 10 June 2023
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 12 (6) , 76-89
Predominance of Wild K13 Propeller Haplotypes in three localities of Côte d'Ivoire one decade after the adoption of Therapeutic Combinations based on Artemisinin Derivatives
- 10 June 2023
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 12 (6) , 76-89
Predominance of Wild K13 Propeller Haplotypes in three localities of Côte d'Ivoire one decade after the adoption of Therapeutic Combinations based on Artemisinin Derivatives